ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Stock Price Pass Below 50-Day Moving Average – What’s Next?

Posted by James Quigley on Nov 14th, 2025

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report)’s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $12.26 and traded as low as $10.06. ProShares UltraShort Nasdaq Biotechnology shares last traded at $10.38, with a volume of 9,457 shares traded.

ProShares UltraShort Nasdaq Biotechnology Trading Up 1.9%

The company’s fifty day simple moving average is $12.26 and its two-hundred day simple moving average is $15.29.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Wednesday, September 24th were paid a dividend of $0.1543 per share. This is a positive change from ProShares UltraShort Nasdaq Biotechnology’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Wednesday, September 24th. This represents a $0.62 dividend on an annualized basis and a dividend yield of 5.9%.

Institutional Investors Weigh In On ProShares UltraShort Nasdaq Biotechnology

A hedge fund recently bought a new stake in ProShares UltraShort Nasdaq Biotechnology stock. Csenge Advisory Group bought a new stake in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) during the third quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 12,421 shares of the company’s stock, valued at approximately $163,000. Csenge Advisory Group owned about 6.54% of ProShares UltraShort Nasdaq Biotechnology as of its most recent filing with the SEC.

About ProShares UltraShort Nasdaq Biotechnology

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.